Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancer.
CONCLUSION: Our results thus demonstrate that spondin 1 is a useful marker for ovarian cancer; additionally, the high percentages of tumors that are positive for spondin 1 make it an ideal target for therapy. CRABP-1 was not expressed at high levels in any subtype of ovarian cancer, making it a poor marker.
PMID: 24294399 [PubMed - in process]
Source: International Journal of Clinical and Experimental Pathology - Category: Pathology Authors: Jiao TT, Zhang YM, Yao L, Gao Y, Sun J, Zou DF, Wu GP, Wang D, Ou J, Hui N Tags: Int J Clin Exp Pathol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Ovarian Cancer | Ovaries | Pathology | Women